ATProto Browser

ATProto Browser

Experimental browser for the Atmosphere

Post

Thousands of women with early breast cancer could be offered a drug to stop the cancer returning, after the medicines watchdog approved its use in England.

Apr 24, 2025, 5:27 PM

Record data

{
  "uri": "at://did:plc:xj2vgfntckid2dl6sa6affmm/app.bsky.feed.post/3lnla5kgjac2a",
  "cid": "bafyreicjdulfodkwb47zptuief6y4ntc4kxr35ky5yph25hgumgt5jpux4",
  "value": {
    "text": "Thousands of women with early breast cancer could be offered a drug to stop the cancer returning, after the medicines watchdog approved its use in England.",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://www.theguardian.com/society/2025/apr/24/ribociclib-drug-cuts-risk-breast-cancer-returning-approved-england?CMP=Share_iOSApp_Other",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreib2qu6ntsjdb5dqp7iylut4u2h2rqwj3mbuywqdpucdoqhl4v7rim"
          },
          "mimeType": "image/jpeg",
          "size": 306143
        },
        "title": "Drug that cuts risk of breast cancer returning is approved for use in England",
        "description": "Up to 4,000 patients a year with early stage of disease could receive ribociclib, but charities want wider access to drug"
      }
    },
    "langs": [
      "en"
    ],
    "createdAt": "2025-04-24T17:27:09.130Z"
  }
}